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Over the past 10 years, increasing evidence has accumulated that heterogeneity is a feature of hematopoietic
stem cell (HSC) proliferation, self-renewal, and differentiation based on examination of these properties at
a clonal level. The heterogeneous behavior of HSCs reflects the operation of a complex interplay of intrinsic
and extrinsic variables. In this review, we discuss key findings from the last 5 years that reveal new insights
into the mechanisms involved.The hematopoietic system has long served as an important
model for delineating both tissue-specific and more generalized
mechanisms that balance cell loss and replacement. Fifty years
ago, the introduction of clonal transplant assays established the
existence of multipotent hematopoietic cells and laid the
conceptual foundation of a hematopoietic stem cell (HSC)
compartment. In the past 10 years, a multitude of pathways
and extrinsic factors that play critical roles in regulating HSC
numbers in vivo have been identified. More recently, evidence
of intrinsic and extrinsic mechanisms regulating the very proper-
ties that define HSCs have emerged. These findings introduce
a new level of complexity into understanding how HSC behavior
is controlled. They thus raise many new challenges, but also
suggest new possibilities for obtaining previously obscured
insights into diseases caused by perturbed HSC function and
into mechanisms of relevance to development, aging, and
regenerative medicine.
Background
Many tissues depend on mechanisms that balance the loss and
renewal of their specialized cellular elements. Early microscopy
of solid tissues with high rates of cell turnover (such as the skin
and gut) suggested that this balance is achieved through amulti-
step, unidirectional developmental process in which mature end
cells are ultimately generated from an initial population of
morphologically undifferentiated precursor (stem) cells. Such
morphological studies led to the concept of tissue-specific
stem cells and intermediate transit-amplifying cells, but were
not well suited to investigations of mechanisms that regulate
their numbers and differentiation behavior. Not surprisingly,
therefore, it was studies of the hematopoietic system, where
the precise location of the stem cells remains controversial,
that led to a new, functional approach for identifying stem cells
based on an analysis of the types of progeny they produce.
This functional approach to hematopoietic stem cell (HSC)
identificationwas launchedby thediscovery that the regenerative
potential of these cells can be activated upon their transplanta-
tion into a host whose blood cell output has been compromised,
e.g., by a lethal dose of irradiation (Ford et al., 1956; Jacobson
et al., 1951). The fact that single HSCs can produce millions of
mature blood cells led to the first efforts to use clonal analyses
for their detection (Becker et al., 1963; Till and McCulloch,690 Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc.1961). Thefirst suchcellswerecalledcolony-formingunits spleen
(CFU-S) based on their ability to producemacroscopically visible
colonies in the spleen in a 1–2 week period, but were subse-
quently found to contain very few cells with longer-term hemato-
poietic repopulating activity (Jones et al., 1996; Ploemacher and
Brons, 1989). Nevertheless, many of the results obtained from
analyzing the behavior of CFU-S have remained relevant to
understanding more primitive subsets of hematopoietic cells.
A key observation that rapidly emerged from the study of
CFU-S was the high degree of variability in the numbers and
types of daughter cells produced in these transplant assays
(Siminovitch et al., 1963; Till et al., 1964). This finding was later
strengthened by analyses of multilineage colonies generated
in vitro, where external stimuli can be kept the same (Humphries
et al., 1979, 1981; Ogawa et al., 1983), and further reinforced by
experiments that used retroviral marking to track clones gener-
ated in vivo over more prolonged periods (Dick et al., 1985;
Lemischka et al., 1986). These findings stimulated subsequent
efforts to elucidate both the local external regulators (‘‘niche’’
control) of HSC behavior and the internal regulators of their
various fate choices (i.e., their viability, proliferative state, self-
renewal probability, and differentiation lineage options).
In the past few decades, most experiments aimed at under-
standing mechanisms regulating HSC functionality have been
designed and the results interpreted based on the assumption
that HSCs can be quantified and characterized using a singular
measurement of their continuing production at a clonal level of
lymphoid and myeloid cells for at least 16 weeks in suitably
compromised hosts (Bryder et al., 2006). This assumption is
based on the concept that the self-renewal potential and differ-
entiation (lineage) potential of HSCs are largely controlled by
a common network of intrinsically specified mechanisms that
establish a common ground state in these cells. This idea is
not to be confused with the extent to which these potentialities
are expressed, because these are known to be subject to micro-
environmental cues. Recent work has now thrown new light onto
these issues and suggests a greater level of heterogeneity in
HSC populations than previously envisaged. Additionally, alter-
ations in HSC properties occur during ontogeny and aging. In
this review, we highlight work from the past 5 years that has
contributed to this growing theme of functional heterogeneity
in HSC biology.
Figure 1. Lymphopoietic Differences between HSC
Subtypes Are Manifested at Multiple Levels of
Lymphoid Differentiation
HSCs with durable self-renewal consist of 2 subtypes
(a-HSCs and b-HSCs). These have equivalent robust myeloid
differentiation ability but they differ in their ability to produce
mature lymphoid cells as shown. The lymphoid deficiency of
a-HSCs results from a multistep reduction in lymphoid cell
output (Benz et al., 2012).
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A major technological development in the last decade was the
introduction of methods for purifying mouse HSCs with long-
term repopulating activity (at least 16 weeks) to near homoge-
neity (Kiel et al., 2005; Osawa et al., 1996). This approach
made it feasible to examine the in vivo clonal outputs of these
HSCs with the certainty that the activity being observed could
be attributed to one as opposed to several cells—a caveat
inherent in limiting dilution approaches. The mature cell outputs
of hundreds of single HSC transplants have now been analyzed,
and for many of these, serial transplants have also been per-
formed to determine the stability of the primary patterns
observed. The results have cemented the controversial idea
that differences in HSC behavior are due to their possession of
different self-renewal and differentiation properties, as first
proposed by studies of Mu¨ller-Sieburg and coworkers using
limiting dilution HSC transplants (Mu¨ller-Sieburg et al., 2002).
Different HSC subtypes have since been defined using
a variety of criteria to distinguish their mature blood cell outputs.
The Mu¨ller-Sieburg group has identified different HSC subsets
as ‘‘myeloid-biased’’ (My-bi), ‘‘lymphoid-biased’’ (Ly-bi), or
‘‘balanced’’ (Bala), based on a measurement of the predominant
lineages within the total output of donor-derived blood cells (i.e.,
exclusive of the recipient’s contribution to, or the total number of,
mature blood cells) (Mu¨ller-Sieburg et al., 2012). We have
distinguished the different differentiation behaviors of individual
HSCs by measuring the relative contributions of individual HSC
outputs to the total circulating myeloid and lymphoid cell
numbers (i.e., those derived from both donor and recipient
HSCs). This different method distinguishes HSC subtypes as
‘‘lymphoid-deficient’’ (a), ‘‘balanced’’ (b), or ‘‘myeloid-deficient’’
(g and d) and both a- and b-HSCs are found to contribute simi-
larly to the circulating pool of myeloid cells (Dykstra et al., 2007).
Serial transplantation experiments have been important in es-
tablishing the concept that the different clonal patterns of differ-
entiation represent intrinsically stable HSC ‘‘programs,’’ as
opposed to temporally or stochastically variable states. Such
experiments have shown that only a- and b-HSCs can be serially
transplanted, and their unique differentiation behaviors are
usually stably maintained over periods of years in primary trans-
plant recipients (Benz et al., 2012; Dykstra et al., 2007). Likewise,
the initial pattern of differentiation by which they are defined is
frequently expressed by their clonally generated daughter
HSCs when these are transplanted into secondary mice (BenzCellet al., 2012; Dykstra et al., 2007, 2011; Mu¨ller-
Sieburg et al., 2002, 2012). However, it is also
apparent that the original HSC program is not
always maintained with complete fidelity asdemonstrated by the generation of secondary b clones from
primary a clones, and vice versa (Benz et al., 2012).
The mechanisms determining the lineage outputs that distin-
guish different HSC subtypes are complex. For example, HSCs
with different lymphoid outputs appear to produce lymphoid
precursors that display differences in their IL-7 responsiveness
(Sieburg et al., 2006). In addition, our group (Benz et al., 2012)
has found that the reduced production of lymphoid cells that is
characteristic of a-HSCs is due to a deficiency that operates at
multiple levels as their progeny attempt to move down the
lymphoid pathway (Figure 1).
At present, methods to prospectively separate different HSC
subtypes are not sufficiently discriminating to enable their differ-
ences to be examined at a molecular level. However, microflui-
dics-based analyses of the transcriptomes of individual cells in
a highly purified HSC population have suggested that additional
subsets may exist based on their nonrandom pattern of expres-
sion of certain genes (Glotzbach et al., 2011). In addition, several
other potential clues have been uncovered. One is the evidence
that TGF-b may influence HSC subtypes differently (Challen
et al., 2010). A second is the finding that the microenvironment
of the bone marrow is a preferential site of enrichment for
a- versus b-HSCs (Benz et al., 2012). A third is the recent obser-
vation that Btaf, a gene found to regulate DNA damage
responses, may differentially influence the maintenance of the
a- versus b-HSC states (Wang et al., 2012).
Taken together, these findings suggest that differences will be
found in the molecular machinery that determines the differenti-
ation potential of individual HSCs, and that such differences will
bemaintained in the clonally derived daughter HSCs produced in
consecutive self-renewal divisions. The impressive stability of
the differentiation behavior that these cells and their progeny
display is consistent with an underlying epigenetic mechanism,
and the recent observation of perturbations in both human and
mouse blood cell lineage outputs associated with alterations in
the DNA methylation machinery provides further support for
this idea (Bro¨ske et al., 2009; Challen et al., 2012; Hodges
et al., 2011; Ji et al., 2010; Trowbridge et al., 2009). Nevertheless,
the inherently artificial nature of the single-cell transplantation
conditions used to characterize the potentialities of individual
HSCs necessarily limits extrapolating such data to under-
standing their activity during normal development, growth, and
aging. In addition, it is still difficult to devise an enrichment
protocol that gives the purities of HSCs required to makeStem Cell 10, June 14, 2012 ª2012 Elsevier Inc. 691
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have been captured.
Cellular barcoding using viruses to introduce unique
sequences into individual HSCs (Gerrits et al., 2010) offers an
important new clonal tracking strategy and also has the potential
to circumvent limitations of single-cell approaches. This tech-
nology uses lentiviral gene transfer to uniquely label the
genomes of individual HSCs, and hence all of their progeny. Its
application to studies of HSC outputs has already enabled these
to be assessed in single mice transplanted with large numbers of
highly purified and individually barcoded HSCs (Lu et al., 2011).
Interestingly, although much greater competitive influences are
expected in this situation compared to previous single HSC
transplantation experiments, the patterns of lineage outputs
were similar in both cases. These findings are significant
because they demonstrate that the mechanisms responsible
for the heterogeneous differentiation behavior of individual
HSCs are not strongly influenced by the number of HSC clones
active in a given (irradiated) mouse.
Cellular barcoding, like the single HSC transplantation
strategy, also has limitations. Because the barcode is delivered
by a viral vector, the HSCs need to be cultured for several hours
to achieve a desirable gene transfer efficiency, which necessarily
alters the properties of the HSCs. In addition, the shorter the
transduction protocol, the less likely the most primitive HSC
subsets will be transduced. Insertion of the viral sequence can
also be mutagenic or at least have functional consequences
that may affect the biology of the cell transduced and/or its
progeny (Cavazzana-Calvo and Fischer, 2007; Cavazzana-Calvo
et al., 2010). Other caveats include the dependence on statistical
assumptions in deriving clone size information from sequencing
barcoded DNA.
Analysis of viral integration sites in engrafted patients from
gene therapy trials has servedasan important sourceof evidence
that long-term clones produced in humans typically produce
both myeloid and lymphoid cells (Cavazzana-Calvo et al., 2011).
However, because these data are derived from transplanted
patients who have severe immune deficiency syndromes, they
might have been influenced by the fact that the regenerated cells
were produced in a setting with a bias toward the detection of
donor-derived lymphoid cells. Of interest, in this regard, is
a recent b-thalassemia patient who was transplanted with
genetically corrected autologous cells and subsequently found
to be reconstituted with a long-lived lymphoid-deficient clone
(Cavazzana-Calvo et al., 2010). Although alternate interpreta-
tions exist, this finding could suggest the existence of
lymphoid-deficient HSC subtypes in humans.
In summary, the clones produced by individual HSCs in irradi-
ated mice display a large range of different lymphoid and
myeloid cell outputs. However, this heterogeneity in differentia-
tion behavior does not appear to be the exclusive result of
random fluctuations in the expression of a multilineage program.
Rather, the heterogeneity seems to reflect the operation of an
intrinsically determined control mechanism that establishes
a unique program in each HSC. Although little is known about
this mechanism, it is clear that it can be perpetuated through
many HSC self-renewal divisions with relatively high, but not
rigidly fixed, fidelity, and that it targets multiple downstream
stages of the lymphoid commitment and differentiation process.692 Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc.HSC Proliferative State Regulation
In adult mice and humans, most of the HSCs are in a prolifera-
tively inactive (quiescent, G0) state. The most recent studies of
the HSC compartment in adult mice indicate that it is composed
of two kinetically distinct subpopulations, with turnover rates of
5 weeks and 21 weeks (termed activated and dormant HSC,
respectively) (Wilson et al., 2008). This conclusion contrasts
with earlier reports that suggested turnover rates of 4–5 weeks
(Bradford et al., 1997; Cheshier et al., 1999), although these latter
rates were based on analyses of a phenotypically defined
compartment that we now understand is predominantly
composed of cells that do not have durable self-renewal activity.
Similar information is not available for human HSCs, but a pro-
longed HSC turnover rate (40 weeks) has also been suggested
(Catlin et al., 2011). These observations raise a number of ques-
tions regarding the differences between activated and dormant
HSCs, including their mechanisms of regulation, whether they
are hierarchically structured or correlate with different lineage
programs, and how their numbers change during ontogeny
and aging.
TGF-b is well known for its ability to arrest the cycling of prim-
itive hematopoietic cells, but evidence that this contributes to the
homeostatic regulation of HSCs in vivo has been inconclusive. In
a recent series of experiments, freshly isolated HSCs were found
to display active TGF-b signaling (Yamazaki et al., 2009), indi-
cating a role for this pathway in vivo. Further corroboration
comes from studies in which HSCs unable to express a TGF-b
receptor demonstrated impaired long-term hematopoiesis and
heightened proliferative activity in transplanted recipients
(Yamazaki et al., 2011). The same group also identified nonmye-
linating Schwann cells as the cells responsible for the activation
of TGF-b in the bone marrow, thereby uncovering a potential
novel role for this cell type as an upstream regulator of TGF-
b-mediated control of HSC quiescence (Yamazaki et al., 2011).
The signaling components responsible for HSC responses to
both proliferative and antiproliferative signals have recently
been further elucidated. Once of these is FOXO3A, which has
been shown to act as an HSC dormancy factor via its ability to
regulate p27 and p57 (Miyamoto et al., 2007). This effect is likely
facilitated by a p27/p57-mediated blockade of the nuclear trans-
port of HSC70/cyclin D1, because a knockout of both of these
genes leads to increased cycling and an associated nuclear
import of this complex (Zou et al., 2011). Changes in the levels
of reactive oxygen species in HSCs and alterations in oxygen-
sensing molecules also appear to be associated with changes
in HSC turnover rates (Miyamoto et al., 2007; Takubo et al.,
2010). However, it remains unclear whether these are a cause
or consequence of changes in HSC cycling. Finally, the tumor
suppressor Lkb1 was recently found to be important for the
maintenance of HSC quiescence because its conditional dele-
tion leads to loss of quiescence followed by rapid HSC depletion
and pancytopenia (Nakada et al., 2010).
HSC Self-Renewal Activity
The concept of distinct subsets of repopulating cells dates back
several decades (Hodgson and Bradley, 1984), and the fact that
they can be prospectively isolated as phenotypically separable
subsets has been recognized for over a decade (Bryder et al.,
2006). However, evidence of different subsets of HSCs with
Figure 2. Differences between Fetal and Adult Mouse
HSCs
Certain key properties of HSCs in fetal and adult tissues differ.
These affect their self-renewal activity, their cycling control,
and their generation of mature myeloid cells. In addition, the
production of B cells from fetal HSCs can proceed in the
absence of IL-7 and thymic stromal-derived lymphopoietin
(TSLP), whereas, in the adult, IL-7 is an absolute requirement.
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tained (Benveniste et al., 2010; Dykstra et al., 2007, 2011; Iscove
and Nawa, 1997; Morita et al., 2010; Sieburg et al., 2011). This
evidence is based on two types ofmeasurements. One is the life-
time of individual HSC-derived clones of mature blood cells
produced in transplanted mice, which are observed to range
from a minimum of 4 months (by definition) to >2 years. The
second more stringent endpoint is the detection of clonally
perpetuated blood cell production that is sustained through at
least three serial transplants; i.e., beyond the lifetime of a normal
mouse. The prolonged maintenance of daughter HSC activity for
at least 6months following secondary transplantation appears to
be associated with the maintenance of robust myeloid differen-
tiation activity that is shared by a- and b-HSCs. In contrast, in
HSCs that have more time-restricted myeloid outputs (interme-
diate HSCs) and/or have become largely restricted to producing
lymphoid cells (g and d subtypes), self-renewal activity is not
usually maintained beyond 4 months after initial transplantation
(Dykstra et al., 2007). Importantly, mouse HSCs with more
limited self-renewal activities can be prospectively distinguished
from those that exhibit durable activity, the latter being most
enriched within a subpopulation that does not express CD49b
and shows the highest expression of CD150 (encoded by
Slamf1) (Benveniste et al., 2010; Kent et al., 2009; Kiel et al.,
2005; Morita et al., 2010).
Steel factor (SF, also known as Kit ligand or Stem Cell Factor
[SCF]), has long been known to play a key role in the control
and maintenance of primitive hematopoietic cells (McCulloch
et al., 1964). New insights obtained in the last 5 years include
the demonstration that SF can rapidly modulate self-renewal
decisions of mouse HSCs, even when other variables, including
cell death and cell cycle progression, are kept constant (Kent
et al., 2008). The cellular origins of SF important for HSC regula-
tion in vivo havealso recently been clarified. Thiswasachievedby
generating different types of transgenic mice in which the Kitl
gene was deleted in a cell-type-specific manner, followed by
analysis of HSC activity. These experiments showed that SF
produced by endothelial and perivascular stromal cells, but not
from osteoblasts, is necessary for mouseHSC regeneration afterCelltransplant (Ding et al., 2012). These findings rein-
force previous studies indicating a role for external
signals in regulating the extent to which adult
HSCs express their innate self-renewal potential
in vivo (Iscove and Nawa, 1997). In addition, cell-
intrinsic mechanisms appear to instruct distinct
heritable self-renewal probabilities in different
HSCs, as suggested by similarities in the longevity
of daughter clones generated from the same clon-
ally expanded primary HSCs (Sieburg et al., 2011).Over the last 2 decades, the many transcription factors, chro-
matin modifiers, and cell cycle regulators that have been found
to affect HSC self-renewal behavior suggest that a number of
different pathways regulate this process. The recently demon-
strated role of epigenetic regulators in affecting HSC self-
renewal adds another layer of complexity (Challen et al., 2012).
However, whether these factors influence self-renewal indepen-
dently of cell survival or proliferation, and how their effects are
ultimately integrated, remains largely obscure.
In summary, our current understanding of mouse HSC self-
renewal control suggests that the probability of undergoing
a self-renewal division and the durability of this behavior is an
intrinsically determined phenomenon that can be modified by
the presence or absence of extrinsic factors. Additionally, the
durability of this activity appears to be tightly linked to the main-
tenance of an active myeloid differentiation program.
HSC Property Changes during Development and Aging
It has been known for decades that primitive hematopoietic cells
within the developing fetus show a much higher turnover than
adult bone marrow HSCs (Becker et al., 1965; Fleming et al.,
1993; Morrison et al., 1995). A pronounced difference between
the proliferative activity of fetal and adult HSCs is now appreci-
ated to be one of several properties of HSCs that change during
development. Others include HSC self-renewal activity in trans-
planted adult recipients (Bowie et al., 2007b; Pawliuk et al.,
1996), the growth-factor dependence of their self-renewal
activity (Bowie et al., 2007a; Ikuta and Weissman, 1992), the
numbers and types of mature cells they produce (Bowie et al.,
2006; Dorshkind and Montecino-Rodriguez, 2007; Ikuta et al.,
1990; Micklem et al., 1972), and the growth-factor requirements
of their lymphoid-restricted progeny (Kikuchi and Kondo, 2006)
(Figure 2). These distinguishing features seem to also be associ-
ated with unique programs because several genes—Bmi1 (Park
et al., 2003), Gfi1 (Hock et al., 2004a), and Tel/Etv6 (Hock et al.,
2004b)—are intrinsically required for the in vivo generation and
maintenance of adult, but not fetal, HSCs.
An important new element has been the revelation that several
of these properties change abruptly and in a highly coordinatedStem Cell 10, June 14, 2012 ª2012 Elsevier Inc. 693
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properties of HSCs that are known to be targeted by this devel-
opmental ‘‘switch’’ include their cycling status, their speed
of expansion after transplantation, and their granulopoietic
activity (Bowie et al., 2006, 2007b). In addition, the cytokine
requirements of their lymphopoietic progeny are altered at this
time (Kikuchi and Kondo, 2006). Remarkably, when fetal HSCs
are transplanted into adult mice, their progeny HSC acquire
adult-like properties (in terms of their granulopoietic output and
posttransplant rate of expansion in secondary hosts) in the
same time frame as they would have done if left unperturbed in
the developing mouse. Taken together, these results suggest
the operation of an intrinsically determined and timed process
responsible for regulating the transition from a fetal to an adult
HSC program.
Changes in the representation of the HSC subtypes (as
defined by their lineage outputs: see discussion of a, b, and g
and d, above) in different tissues also occur during ontogeny.
This change, however, does not share a similar timing with the
changes that alter HSC proliferative activity and self-renewal
control (Benz et al., 2012). In fact, no change in HSC subtype
distribution is seen between 3 and 4 weeks of age in the mouse;
i.e., the interval during which other HSC properties coordinately
switch from a fetal to an adult program. However, a change in
HSC subtype distribution does occur, but much earlier, starting
in the late embryo and correlating with the relocation of HSCs
from the liver to the bone marrow. These findings suggest that
the mechanism regulating the changes in the subtype composi-
tion of the HSC pool involves extrinsic factors emanating from
the bone marrow microenvironment and is uncoupled from the
mechanism that regulates the fetal-to-adult switch in cycling
and self-renewal control, which appears to be intrinsically regu-
lated (Benz et al., 2012).
Evidence for a similar fetal-to-adult switch in humans was
initially implied by themarked decrease in the rate of granulocyte
telomere shortening seen in children between the age of 1 and 2
years, suggesting a change in the cycling status of the HSC
compartment (Rufer et al., 1999). One difficulty of these studies
is the wide variability in normal granulocyte telomere length,
which makes firm conclusions in humans difficult to draw.
Subsequently, however, longitudinal measurements of telomere
length in the blood cells of baboons have shown similar results to
those from the human studies, further corroborating the idea that
primates also show an abrupt change in HSC cycling during the
early period of their development (Baerlocher et al., 2007).
A possible regulatory component of the fetal-to-adult HSC
switch is the transcription factor SOX17. The Sox17 gene was
recently found to be expressed at a higher level in fetal HSCs
than that in adult HSCs, as determined by both direct measure-
ments of gene expression and an analysis of HSCs isolated from
a Sox17 knockin reporter mouse (Kim et al., 2007). Inducible
deletion of the Sox17 gene was then used to demonstrate an
essential role for SOX17 in maintaining HSCs in fetal/neonatal
mice. Importantly, Sox17 deletion in adult mice had no effect
on HSC numbers or functionality (Kim et al., 2007). These find-
ings provided the first example of a gene product required
specifically for the survival of fetal, but not adult, HSCs, and
therefore evidence for a fetal-specific HSC transcriptional
program. This idea is further supported by the demonstration694 Cell Stem Cell 10, June 14, 2012 ª2012 Elsevier Inc.that Ezh2 is similarly required for the maintenance of fetal, but
not adult, HSCs (Mochizuki-Kashio et al., 2011). Interestingly,
forced expression of Sox17 in adult murine hematopoietic cells
was found to enhance the HSC-derived output of myeloid cells
(a fetal HSC property) (He et al., 2011), consistent with a partial
reactivation of the fetal program.
Another recently identified potential regulator of fetal versus
adult HSC identity is Lin28b. Lin28b is expressed at higher levels
in fetal lymphoid progenitor populations than those seen in adult
populations, and forced overexpression of Lin28 in adult hema-
topoietic progenitors reactivates a fetal-like lymphoid differenti-
ation program (Yuan et al., 2012). These authors also found that
Lin28b is differentially expressed in fetal and adult HSC-contain-
ing populations (LinSca-1+c-Kit+ cells), suggesting that LIN28B
may also regulate differences between their developmental
states. Since LIN28 acts as a regulator of developmental timing
in C. elegans by inhibiting let-7 microRNA processing (Bu¨ssing
et al., 2008), this pathway may serve as a conserved regulator
of developmental changes in cell properties as animals transition
from a fetal to an adult stage.
Recent studies have also identified changes affecting the HSC
compartment during the aging process. One of these relates to
the decreased level of lymphoid cells (and hence increased
proportion of myeloid cells) seen in the peripheral blood of older
mice and humans (Berkahn and Keating, 2004). This is known to
be associated with a concomitant decrease in committed
lymphoid progenitor numbers (Miller and Allman, 2003; Min
et al., 2006; Rossi et al., 2005), but a gradual ascendency within
theHSCcompartment of lymphoid-deficientHSCshas alsobeen
reported (Beerman et al., 2010; Benz et al., 2012; Cho et al.,
2008). In addition, it has been shown that serial transplantation
of young adult HSCs in young adult recipients selectively
expands/produces lymphoid-deficient HSCs, demonstrating
that these changes donot dependon an agingmicroenvironment
(Dykstra et al., 2011). Thus, multiple HSC-related mechanisms of
how aging may lead to a decline in lymphoid cells are likely rele-
vant (Figure 3). Thesemechanismsmay include a gradual erosion
of lymphopoietic activity across a homogeneous population of
HSCs (Model 1), a gradual dominance of a lymphoid-deficient
HSC subtype (Model 2), or a conversion of lymphoid-competent
to lymphoid-deficient HSC subtypes (Model 3).
Evidence of an age-related increase in lymphoid-deficient
HSCs in older people (Park et al., 2003) suggests that the find-
ings in mice will likely have human correlates. The gradual
dominance of the murine HSC population by lymphoid-deficient
HSCs has been postulated to reflect a proliferative or self-
renewal advantage of these cells (Beerman et al., 2010; Cho
et al., 2008). Another possible mechanism would be the recently
demonstrated ability of lymphoid-competent HSCs to generate
lymphoid-deficient HSC progeny (Benz et al., 2012).
Accumulation of DNA damage within HSCs has been
proposed as a mechanism that contributes to age-associated
decreases in their functionality. Although there has been little
experimental data to support or refute this hypothesis, a recent
study found that mice defective in mediators of DNA-damage
regulators do not manifest changes in the size or composition
of their HSC pool under homeostatic conditions. However,
when transplanted, their HSCs did show increased apoptosis,
reduced reconstituting activity, and decreased self-renewal
Figure 3. Theoretical Models of HSC-Mediated Mechanisms that
May Contribute to Aging-Associated Decreases in the Output of
Mature Lymphoid Cells
In Model 1, hematopoiesis is sustained by the progeny of a homogeneous
population of HSCs (red) that undergo a gradual erosion of their intrinsic
lymphoid differentiation ability over time (blue). In Model 2, aging is associated
with a clonal expansion of lymphoid-deficient HSCs (a-subtype, pale blue) with
a concomitant depletion of lymphoid-competent HSCs (b-subtype, pink). In
Model 3, there is a gradual ascendancy of a-HSCswith aging as a result of their
derivation from b-HSCs. Current experimental data indicate that all of these
models could be operative but are also insufficient to discriminate their relative
importance.
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evidence that normal HSCs do accumulate DNA damage with
age, now provide formal support for a mechanistic connection.
Accumulation of oxidative DNA damage appears to have
a similar influence on human HSCs (Yahata et al., 2011). In
contrast to genomic DNA damage, mitochondrial DNA muta-
tions do not change HSCs functions but profoundly alter the
downstream, differentiating progenitors the HSCs generate
(Norddahl et al., 2011).
Many of the changes in HSCs that occur during early develop-
ment and aging are likely governed by shared as well as distinct
mechanisms. For example, the fetal-to-adult HSC transition
seems to influence most HSCs independently of their differenti-
ation subtype, whereas the age-related changes in the periph-
eral blood composition in aging mice and humans appear to
involve alterations in the relative prevalence of different HSC
subtypes in the total HSC compartment. Additionally, other
changes are likely to be caused by general mechanisms of
senescence (Dykstra et al., 2011), which are overlaid on the
aging-related mechanisms that affect the subtype make-up of
the HSC compartment.
Conclusion
The body of work outlined in this review highlights the reality of
heterogeneity in multiple biological properties of HSCs. These
include their self-renewal, proliferation, and lineage output.Some of these behaviors appear to be coordinately regulated,
whereas others have been clearly shown to be temporally
separable. Interestingly, most involve an integration of both
intrinsically established ‘‘states’’ and variable cues from the
environment.
Current reliance on transplantation strategies to identify HSCs,
although powerful and highly informative, may be less useful for
elucidating processes that control blood cell production under
physiological conditions. In addition, recent findings are largely
based on studies of HSCs in mice or other model organisms
and thus still await validation in humans. Advances in human
HSC purification (Majeti et al., 2007; Notta et al., 2011) have
extended earlier evidence of multiple human hematopoietic
cell types with different self-renewal properties, and an
increasing panoply of immunodeficient xenograft hosts (Doula-
tov et al., 2012) can be expected to facilitate their further charac-
terization in the near future. With the ongoing explosion of new
technologies to analyze single HSC responses, their molecular
composition, and their location in situ, the future of HSC biology
looks both challenging and rosy for those prepared to let go of
old dogma and search for new mechanisms.
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